|
Toronto, Canada, October 19, 2005 –
The construction and build-out of our cGMP scale-up and
manufacturing plant is in the final stages. Manufacturing
equipment has been installed and is in the process of
being commissioned. Our testing laboratories and the
manufacturing facility will shortly be inspected by the
appropriate regulatory agencies to confirm that they are
in full cGLP/cGMP compliance. The completion of this phase
will represent a critical milestone in our evolution.
The 25,000 sq. ft. facility will then include executive
offices, full cGLP analytical laboratories, and a
state-of-the-art cGMP scale-up and manufacturing plant. It
will enable the Company to carry out the entire drug
development process at this single site, including all
analytical chemistry, formulation, pilot batch
manufacture, industrial process scale-up, production of
batches for full-scale clinical trials, stability testing,
regulatory filing, and some commercial scale
manufacturing, labeling, packaging, warehousing and
distribution. The facility will be used for both pipeline
and partnered drug development projects, as well as for
third party contract manufacturing when time permits.
|
Other
Recent News